statistiche ricercatore

Continente	#
NA - Nord America	1.254
EU - Europa	408
AS - Asia	154
SA - Sud America	28
Continente sconosciuto - Info sul continente non disponibili	3
OC - Oceania	2
AF - Africa	1
Totale	1.850

Nazione	#
US - Stati Uniti d'America	1.248
GB - Regno Unito	170
IT - Italia	71
SE - Svezia	55
CN - Cina	51
SG - Singapore	44
DE - Germania	33
BR - Brasile	21
UA - Ucraina	21
FI - Finlandia	18
TR - Turchia	18
HK - Hong Kong	14
BG - Bulgaria	10
BE - Belgio	9
MY - Malesia	8
IN - India	7
IE - Irlanda	6
RU - Federazione Russa	6
AN - Antille olandesi	4
ID - Indonesia	4
PE - Perù	4
PL - Polonia	4
A2 - ???statistics.table.value.countryCode.A2???	2
AU - Australia	2
FR - Francia	2
PH - Filippine	2
TH - Thailandia	2
AR - Argentina	1
BD - Bangladesh	1
BO - Bolivia	1
CA - Canada	1
CO - Colombia	1
EU - Europa	1
HN - Honduras	1
IR - Iran	1
JP - Giappone	1
LT - Lituania	1
RO - Romania	1
RS - Serbia	1
VN - Vietnam	1
ZA - Sudafrica	1
Totale	1.850

Nome	#
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series	255
Simultaneous measurement of adenosine, dopamine, acetylcholine and 5-hydroxytryptamine in cerebral mice microdialysis samples by LC–ESI-MS/MS	230
Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments	212
D2R–striatopallidal neurons inhibit both locomotor and drug reward processes	192
Ryanodine receptor-2 upregulation and nicotine-mediated plasticity.	182
An improved LC-S/MS method for the quantitation of adenosine concentration in mice brain microdialysates.	178
Structural and functional diversity of native brain neuronal nicotinic receptors	177
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.	176
The safety of iloprost in systemic sclerosis in a real-life experience	170
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study	101
Totale	1.873

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	231	0	0	0	0	0	55	64	32	29	13	26	12
2020/2021	439	24	11	16	23	38	20	158	41	14	57	27	10
2021/2022	237	9	36	8	5	7	11	22	8	34	26	46	25
2022/2023	235	32	40	24	26	18	33	4	17	27	0	8	6
2023/2024	125	4	14	10	22	14	13	5	11	5	5	8	14
2024/2025	222	14	5	6	37	98	62	0	0	0	0	0	0
Totale													1.873